Age-Related Macular Degeneration
Injectable drugs decrease risk of blindness-related nursing home admission by nearly 20%, researchers findFebruary 03, 2014
Injectable drugs introduced in the last decade have proven effective in preserving vision and preventing nursing home admissions among those with age-related wet macular degeneration, according to recently published research.
The cheaper of the two rival macular degeneration treatments could lead to blindness or other adverse events, new research determined.
Daily doses of aspirin in elderly adults can double the risk for developing the "wet" version of age-related macular degeneration (AMD), according to a new study.
Injections of the cancer drug Avastin, which is also a treatment for the wet form of age-related macular degeneration, has been linked to reports of blindness.